{"count":220377,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2062","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2060","results":[{"created":"2019-12-07T18:18:51.916756+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.824","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NDUFA11 were set to ","entity_name":"NDUFA11","entity_type":"gene"},{"created":"2019-12-07T18:18:42.974139+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.823","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NDUFA11 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NDUFA11","entity_type":"gene"},{"created":"2019-12-07T18:18:30.482857+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.822","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NDUFA11 as Amber List (moderate evidence)","entity_name":"NDUFA11","entity_type":"gene"},{"created":"2019-12-07T18:18:30.475398+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.822","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndufa11 has been classified as Amber List (Moderate Evidence).","entity_name":"NDUFA11","entity_type":"gene"},{"created":"2019-12-07T18:18:19.263080+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.821","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NDUFA11: Rating: AMBER; Mode of pathogenicity: None; Publications: 18306244, 31074871; Phenotypes: Mitochondrial complex I deficiency, nuclear type 14, MIM#618236; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NDUFA11","entity_type":"gene"},{"created":"2019-12-07T18:14:31.183208+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.821","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NDUFA10 as ready","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:14:31.175967+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.821","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndufa10 has been classified as Green List (High Evidence).","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:14:27.309428+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.821","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NDUFA10 were changed from  to Mitochondrial complex I deficiency, nuclear type 22, MIM#618243","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:14:13.924667+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.820","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: NDUFA10 were set to ","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:14:01.811472+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.819","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NDUFA10 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:13:45.242683+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.818","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NDUFA10: Rating: GREEN; Mode of pathogenicity: None; Publications: 21150889, 26741492; Phenotypes: Mitochondrial complex I deficiency, nuclear type 22, MIM#618243; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NDUFA10","entity_type":"gene"},{"created":"2019-12-07T18:11:00.190168+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.818","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NDN as ready","entity_name":"NDN","entity_type":"gene"},{"created":"2019-12-07T18:11:00.182016+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.818","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndn has been classified as Red List (Low Evidence).","entity_name":"NDN","entity_type":"gene"},{"created":"2019-12-07T18:10:55.209737+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.818","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NDN as Red List (low evidence)","entity_name":"NDN","entity_type":"gene"},{"created":"2019-12-07T18:10:55.202188+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.818","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ndn has been classified as Red List (Low Evidence).","entity_name":"NDN","entity_type":"gene"},{"created":"2019-12-07T18:10:43.671917+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.817","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NDN: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"NDN","entity_type":"gene"},{"created":"2019-12-07T18:08:17.733170+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.817","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NAGS as ready","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:08:17.725693+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.817","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nags has been classified as Red List (Low Evidence).","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:08:08.051510+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.817","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NAGS were changed from  to N-acetylglutamate synthase deficiency, MIM#237310","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:07:58.931234+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.816","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: NAGS was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:07:51.985689+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.815","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: NAGS as Red List (low evidence)","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:07:51.976903+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.815","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: nags has been classified as Red List (Low Evidence).","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:07:39.295717+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.814","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NAGS: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: N-acetylglutamate synthase deficiency, MIM#237310; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"NAGS","entity_type":"gene"},{"created":"2019-12-07T18:03:28.910971+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPS16 as ready","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:03:28.903729+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:03:25.198690+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MRPS16 were changed from  to Combined oxidative phosphorylation deficiency 2; OMIM #610498","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:03:03.318536+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MRPS16 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:02:41.522795+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MRPS16 were set to ","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:02:20.217464+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPS16 as Amber List (moderate evidence)","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T18:02:20.208755+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:52.990834+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPS16 as ready","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:52.982898+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:52.741933+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPS16 as ready","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:52.733732+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:45.441115+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MRPS16 were changed from  to Combined oxidative phosphorylation deficiency 2; OMIM #610498","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:32.086240+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.181","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MRPS16 were set to ","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:59:10.319727+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.180","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MRPS16 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:58:54.621555+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.179","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPS16 as Amber List (moderate evidence)","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:58:54.610871+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.179","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:53.346967+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPS16 as ready","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:53.338698+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:52.903693+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPS16 as Amber List (moderate evidence)","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:52.898355+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment on list classification: Amber for mitochondrial.","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:52.875429+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:35.624228+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MRPS16 were changed from  to Combined oxidative phosphorylation deficiency 2; OMIM #610498","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:18.471354+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MRPS16 were set to ","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:54:01.919372+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MRPS16 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:53:45.579282+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPS16 as Amber List (moderate evidence)","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:53:45.566099+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment on list classification: Amber for mitochondrial.","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:53:45.355527+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrps16 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPS16","entity_type":"gene"},{"created":"2019-12-07T17:40:14.785733+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.177","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPL3 as ready","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:40:14.778341+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.177","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrpl3 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:40:07.173631+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.177","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MRPL3 were changed from  to Combined oxidative phosphorylation deficiency 9; OMIM #614582","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:39:52.706533+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.176","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MRPL3 were set to ","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:39:37.547201+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.175","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MRPL3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:39:24.227007+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.174","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPL3 as Amber List (moderate evidence)","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:39:24.219088+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.174","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrpl3 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:33:20.256242+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MRPL3 as ready","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:33:20.247657+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrpl3 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:33:17.161084+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MRPL3 were changed from  to Combined oxidative phosphorylation deficiency 9; OMIM #614582","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:32:57.209755+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MRPL3 were set to ","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:32:36.517076+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MRPL3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:32:11.207491+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MRPL3 as Amber List (moderate evidence)","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:32:11.193169+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mrpl3 has been classified as Amber List (Moderate Evidence).","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T17:31:44.464460+11:00","panel_name":"Mitochondrial_AustralianGenomics_VCGS","panel_id":203,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MRPL3: Rating: AMBER; Mode of pathogenicity: None; Publications: 27815843, 21786366; Phenotypes: Combined oxidative phosphorylation deficiency 9, OMIM #614582; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MRPL3","entity_type":"gene"},{"created":"2019-12-07T13:36:32.753547+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.814","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CLCN2 as ready","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:36:32.745842+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.814","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: clcn2 has been classified as Amber List (Moderate Evidence).","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:36:26.732930+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.814","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CLCN2 were changed from  to Leukoencephalopathy with ataxia, MIM#615651","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:36:18.326639+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.813","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CLCN2 were set to ","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:36:09.589625+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.812","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CLCN2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:35:58.874497+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.811","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CLCN2 as Amber List (moderate evidence)","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:35:58.866319+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.811","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: clcn2 has been classified as Amber List (Moderate Evidence).","entity_name":"CLCN2","entity_type":"gene"},{"created":"2019-12-07T13:35:36.925817+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.810","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CISD2 as ready","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:35:36.918542+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.810","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cisd2 has been classified as Red List (Low Evidence).","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:35:32.439079+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.810","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CISD2 were changed from  to Wolfram syndrome 2, MIM#604928","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:35:21.912189+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.809","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CISD2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:35:15.459948+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.808","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CISD2 as Red List (low evidence)","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:35:15.452117+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.808","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cisd2 has been classified as Red List (Low Evidence).","entity_name":"CISD2","entity_type":"gene"},{"created":"2019-12-07T13:34:48.644855+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.807","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CHST14 as ready","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:48.637868+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.807","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chst14 has been classified as Amber List (Moderate Evidence).","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:43.795807+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.807","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CHST14 were changed from  to Ehlers-Danlos syndrome, musculocontractural type 1, MIM#601776","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:28.947712+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.806","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CHST14 were set to ","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:19.382665+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.805","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CHST14 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:13.292654+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.804","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CHST14 as Amber List (moderate evidence)","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:34:13.284092+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.804","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chst14 has been classified as Amber List (Moderate Evidence).","entity_name":"CHST14","entity_type":"gene"},{"created":"2019-12-07T13:33:40.149137+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.803","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CACNA1E as ready","entity_name":"CACNA1E","entity_type":"gene"},{"created":"2019-12-07T13:33:40.142210+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.803","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacna1e has been classified as Green List (High Evidence).","entity_name":"CACNA1E","entity_type":"gene"},{"created":"2019-12-07T13:33:34.610752+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.803","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CACNA1E as Green List (high evidence)","entity_name":"CACNA1E","entity_type":"gene"},{"created":"2019-12-07T13:33:34.600463+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.803","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cacna1e has been classified as Green List (High Evidence).","entity_name":"CACNA1E","entity_type":"gene"},{"created":"2019-12-07T13:32:59.160632+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.802","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ATAD1 as ready","entity_name":"ATAD1","entity_type":"gene"},{"created":"2019-12-07T13:32:59.153685+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.802","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atad1 has been classified as Green List (High Evidence).","entity_name":"ATAD1","entity_type":"gene"},{"created":"2019-12-07T13:32:53.847962+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.802","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ATAD1 as Green List (high evidence)","entity_name":"ATAD1","entity_type":"gene"},{"created":"2019-12-07T13:32:53.840171+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.802","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: atad1 has been classified as Green List (High Evidence).","entity_name":"ATAD1","entity_type":"gene"},{"created":"2019-12-07T13:32:18.453390+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.801","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ASTN1 as ready","entity_name":"ASTN1","entity_type":"gene"},{"created":"2019-12-07T13:32:18.446467+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.801","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: astn1 has been classified as Green List (High Evidence).","entity_name":"ASTN1","entity_type":"gene"},{"created":"2019-12-07T13:32:12.269174+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.801","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ASTN1 as Green List (high evidence)","entity_name":"ASTN1","entity_type":"gene"},{"created":"2019-12-07T13:32:12.262173+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.801","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: astn1 has been classified as Green List (High Evidence).","entity_name":"ASTN1","entity_type":"gene"},{"created":"2019-12-07T13:31:47.122294+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.800","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ASH1L as ready","entity_name":"ASH1L","entity_type":"gene"},{"created":"2019-12-07T13:31:47.115178+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.800","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ash1l has been classified as Green List (High Evidence).","entity_name":"ASH1L","entity_type":"gene"},{"created":"2019-12-07T13:31:41.393066+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.800","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ASH1L as Green List (high evidence)","entity_name":"ASH1L","entity_type":"gene"}]}